Furthermore, Grabosch et al. demonstrated that neoadjuvant chemotherapy with cisplatin enhanced tumor immunogenicity and upregulated PD-L1 expression in ovarian cancer mouse models. The gene discussed is CD274; the disease is neoplasm.